perpetual patches bpc 157 BPC-157 Peptide Therapy Beverly Hills InjectAbility Clinic in Torrance, CA

Hulett NA, Scalzo RL, Reusch JEB

(Stimulated Egr-1 gene, NAB2, FAK-paxillin and JAK-2 pathways) BPC-157 Uses ORAL: 250-500 mcg by mouth daily in 1-2 divided doses SUBQ: 250-500mcg subcutaneously once-twice daily INTRAMUSCULAR: 250-500mcg as close to the site of injury as possible QD-BID SUBLINGUAL: 200-500 mcg between cheek and gum daily in 1-2 divided doses BPC-157 used to treat injuries We will use the ACL tendon in the knee as an example for this article

Subscribe now for unlimited digital access to our award-winning business news.

AHK-Cu specifically influences three major mechanisms that matter for hair and skin